Department of Radiology, University of Chicago Medical Center, University of Chicago, Chicago, Illinois.
Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
J Vasc Interv Radiol. 2024 Dec;35(12):1847-1854.e1. doi: 10.1016/j.jvir.2024.08.023. Epub 2024 Sep 2.
To demonstrate the safety and effectiveness of a computer-assisted large-bore thrombectomy (CA-LBT) device in aspiration thrombectomy for treatment of deep vein thrombosis (DVT).
A single-institution retrospective review was performed to include 16 consecutive patients (median age, 51.1 years; range, 19-77 years; 5 men and 11 women) who underwent percutaneous thrombectomy using a 16-F CA-LBT device (Lightning Flash Aspiration System; Penumbra, Alameda, California) for DVT (12 iliofemoral occlusions with or without caval extension [75.0%], 3 axillosubclavian occlusions [18.8%], and 1 caval occlusion [6.3%]) between January 2023 and August 2023.
Thrombectomy was performed via the popliteal (n = 10, 62.5%), femoral (n = 3, 18.8%), saphenous (n = 1, 6.3%), brachial (n = 1, 6.3%), and femoral and brachial (n = 1, 6.3%) veins, with a median fluoroscopy time of 17 minutes (range, 7.2-61 minutes) and contrast agent volume of 110 mL (range, 30-175 mL). Restoration of anterograde flow was achieved in all cases (100%, 16/16). Thirteen patients (81.2%) received venoplasty after thrombectomy for residual stenosis. Stents were placed in 7 patients (43.8%). With a median clinical follow-up of 77 days (range, 3-278 days), symptom improvement was achieved among 13 of 15 patients (86.7%) who initially presented with DVT-associated symptoms. Of 14 patients with imaging follow-up, patency was confirmed in 12 (85.7%). Of the 2 patients (14.3%) with complete thrombosis on follow-up imaging, one patient was successfully treated with repeated thrombectomy using CA-LBT technology and the other was treated with systemic anticoagulation.
Aspiration thrombectomy with this 16-F CA-LBT device is a feasible option for treatment of proximal or large-volume DVT.
展示一种新型计算机辅助大口径血栓切除术(CA-LBT)设备在抽吸血栓切除术治疗深静脉血栓形成(DVT)中的安全性和有效性。
本研究为单中心回顾性研究,纳入 2023 年 1 月至 2023 年 8 月期间采用 16-F CA-LBT 装置(Lightning Flash Aspiration System;Penumbra,加利福尼亚州阿拉米达)治疗 16 例接受经皮血栓切除术的 DVT 患者(12 例髂股静脉闭塞合并或不合并腔静脉延伸[75.0%],3 例锁骨下-腋静脉闭塞[18.8%],1 例腔静脉闭塞[6.3%])。患者的中位年龄为 51.1 岁(范围 19-77 岁);5 例男性,11 例女性。
10 例(62.5%)患者经腘静脉入路、3 例(18.8%)经股静脉入路、1 例(6.3%)经大隐静脉入路、1 例(6.3%)经肱静脉入路、1 例(6.3%)经股静脉和肱静脉入路进行血栓切除术。透视时间中位数为 17 分钟(范围 7.2-61 分钟),造影剂用量中位数为 110mL(范围 30-175mL)。所有患者均成功实现顺行血流恢复(100%,16/16)。13 例(81.2%)患者在血栓切除术后接受静脉成形术以治疗残余狭窄。7 例(43.8%)患者置入支架。中位临床随访时间为 77 天(范围 3-278 天),15 例(86.7%)初始存在 DVT 相关症状的患者中,13 例症状得到改善。14 例有影像学随访的患者中,12 例(85.7%)确认血管通畅。2 例(14.3%)患者在随访影像学检查中完全血栓形成,其中 1 例患者再次采用 CA-LBT 技术成功接受血栓切除术治疗,另 1 例患者接受全身抗凝治疗。
采用这种 16-F CA-LBT 装置进行抽吸血栓切除术是治疗近端或大容量 DVT 的可行选择。